New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

2

Pfizer’s NASH Treatment Lands FDA Fast Track Designation

On Thursday, Pfizer announced the U.S. Food and Drug Administration granted the company’s combinatorial therapeutic ervogastat/clesacostat Fast Track Designation. The therapeutic combo is intended for the treatment of non-alcoholic steatohepatitis (NASH) with liver fibrosis.

5

The next U.S. abortion battle is over pills, and it’s already begun

The U.S. Supreme Court has not yet released its decision that looks set to dramatically scale back abortion rights, but one of the next legal battles has already begun in a Mississippi court. That is where the manufacturer of a pill used to carry out medication abortions, Las Vegas-based GenBioPro Inc., has filed a federal lawsuit challenging the conservative state’s restrictions on the pill, used in more than half of all U.S. abortions.

10

Roche develops test kits to detect monkeypox virus

Roche on Wednesday said the company and its unit have developed three test kits to detect the monkeypox virus, as the disease spreads in regions outside Africa, where the virus is not normally found.